Analyst Ratings For Illumina
Illumina (NASDAQ:ILMN) has observed the following analyst ratings within the last quarter:
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's session, 454 stocks hit new 52-week lows.
Tataa Biocenter Is Partnering With Olink and Illumina to Offer High Performance Proteomics With Unprecedented Throughput
"Olink® EXPLORE 3072 is the perfect complement to our already optimized genomics and transcriptomics offerings and will be imperative in our services supporting the pharmaceutical industry," said Mikael Kubista, founder and CEO of Tataa Biocenter. "We already offer workflow optimization and validation including multiomics, and with this new platform, our capacity dramatically increases."
CNBC’s Final Trades: iShares MSCI UK, Illumina, US Silica And This Company That Has An Attractive Buyout Deal
On CNBC’s “Halftime Report Final Trades,” Liz Young of BNY Mellon Investment Management chose iShares MSCI United Kingdom ETF (NYSEARCA: EWU), saying that the opportunities in Europe were “insulated from Fed rate hikes, a
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 505 companies set new 52-week lows.
Barron’s Latest Picks And Pans: Zillow, Coca Cola, Illumina, Spotify And More
This weekend's Barron's cover story says there will be a dramatic increase in betting on this year's Super Bowl, a trend that's likely to continue for years to come.
What 5 Analyst Ratings Have To Say About Illumina
Analysts have provided the following ratings for Illumina (NASDAQ:ILMN) within the last quarter: